+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Botulinum Toxin - Global Strategic Business Report

  • PDF Icon

    Report

  • 353 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 516890

Global Botulinum Toxin Market to Reach $11 Billion by 2030

The global market for Botulinum Toxin estimated at US$6.1 Billion in the year 2023, is projected to reach a revised size of US$11 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030.

Type A Botulinum Toxin, one of the segments analyzed in the report, is projected to record 7.7% CAGR and reach US$11 Billion by the end of the analysis period. Growth in the Type B Botulinum Toxin segment is estimated at 6.5% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3.6 Billion, While China is Forecast to Grow at 14% CAGR

The Botulinum Toxin market in the U.S. is estimated at US$3.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 14% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.5% and 6.4% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 8.4% CAGR.

Exciting New Report Features

  • Full access to influencer engagement stats
  • Free access to digital archives & research platform. The proprietary platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. The state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
  • Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
  • Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
  • Complimentary report updates for one year
  • Competitor coverage with global market shares of major players
  • Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
  • Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes

What to Expect from the Global Economy in 2024

Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.

Select Competitors (Total 28 Featured)

  • AbbVie Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Evolus, Inc.
  • Galderma SA
  • Daewoong Pharmaceutical Co., Ltd.
  • Revance Therapeutics, Inc.
  • Protox Co., Ltd.
  • Medy-Tox
  • Jetema Co., Ltd.
  • Hugel, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Botulinum Toxin - Global Key Competitors Percentage Market Share in 2023 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
  • Botulinum Toxin: An Introduction
  • Outlook
  • Therapeutic BTX Applications Lead
  • Cosmetic BTX Gradually Gains Momentum
  • Factors Propelling the Cosmetic BT Market: In a Nut Shell
  • Developed Regions Dominate Botulinum Toxin Market
  • Developing Markets to Drive Future Growth
  • Competitive Landscape
  • Intense Competition Characterizes Botulinum Toxin Market
  • Select Approved Botulinum Toxin Products Worldwide
  • Companies Entering the Fray
  • Pharma Companies Eye Lucrative BT Market
  • Biosimilar BTX Variants Challenge Botox’s Leadership
  • Lack of Differentiation among Approved BTX Products
  • Comparison of Leading Neurotoxins - Botox, Dysport and Xeomin by Safety and Efficacy
  • Comparison of Botox®, Dysport® and Xeomin® by Indications and Year of Approval
  • BOTOX®
  • Approvals and Indications of Botox in Select Regions
  • Botox Therapeutic Approvals in the US by Indication
  • Ipsen Counts on New Indications for Future Growth of Dysport
  • Xeomin®
  • Merz
  • Other Products
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Demand for Non-Invasive Cosmetic Treatments Bodes Well for BTX Market
  • Botulinum Toxin: The Preferred Solution in Facial Injectables Market
  • Millennials: A Popular Demographic for Botulinum Toxin
  • Therapeutic Areas and Opportunities
  • Botox Therapeutic Applications Uses and Indications
  • Botulinum Toxin Remains Gold Standard for Treatment of Focal Spasticity
  • Rise in the Number of Musculoskeletal Indications: Potential for Growth
  • Unmet Medical Needs Encourage Off-Label Use: A Cause for Concern or Jubilation?
  • Combination Therapies: A Double Whammy Success
  • Botulinum Toxin: Potential Applications in Treatment of Dental Diseases
  • Potential Applications in Dentistry
  • Short-lived Aesthetic Effects: A Strong Business Case for Revision Treatments
  • Novel Injection Systems for Highly Precise Dosage of Botulinum Toxin
  • Longer Life Expectancy and Rising Disposable Incomes Propel Sales of Cosmetic BTX
  • Life Expectancy at Birth in Years of People in Select Countries
  • Life Expectancy at Birth (in Years) of Men and Women by Region
  • Increase in Healthcare Spending Stirs Demand for BTX in Therapeutic Applications
  • Challenges and Issues
  • Undesirable Side Effects: A Challenge to Reckon With
  • Immunogenicity Undermines Patient Compliance
  • Antigenicity: A Problematic Issue in Drug Development
  • Potential Adverse Side Effects: A Major Barrier to Success
  • Stringent Regulations Delay Market Approvals
  • Higher Product Costs to Challenge Market Growth
  • Consumer Skepticism: The Biggest Challenge to Beat
  • Animal Cruelty:A Part & Parcel of Botox Testing
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 2: World Historic Review for Botulinum Toxin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 3: World 16-Year Perspective for Botulinum Toxin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2024 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 5: World Historic Review for Type A by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 6: World 16-Year Perspective for Type A by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 8: World Historic Review for Type B by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 9: World 16-Year Perspective for Type B by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 11: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 12: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 14: World Historic Review for Aesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 15: World 16-Year Perspective for Aesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 16: World Recent Past, Current & Future Analysis for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 17: World Historic Review for Specialty & Dermatology Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 18: World 16-Year Perspective for Specialty & Dermatology Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 20: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 21: World 16-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 22: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
  • Table 23: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
  • Table 24: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2024 & 2030
  • Table 25: World Botulinum Toxin Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • Market Overview
  • Opportunities in Store for Cosmetic BTX
  • Increasing Demand for Cosmetic Treatments Bodes Well for BTX Market
  • Aging Baby Boomers Drive Aesthetic Business
  • North American Aging Population by Age Group: 1975-2050
  • Expanding Physician Base Extends Impetus to Growth
  • Therapeutic BTX Seeks Growth Opportunities
  • Approved Therapeutic Indications of Botulinum Toxin in the US by Year of Approval
  • Neurogenic OAB: A Lucrative Market Opportunity
CANADA
JAPAN
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • Market Overview
  • Botox Approvals and Indications in Select European Countries
  • Regulations for Botulinum Toxin Usage in the EU
FRANCE
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • Market Overview
  • Snapshots
SPAIN
RUSSIA
  • Market Overview
REST OF EUROPE
ASIA-PACIFIC
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in Australia (2019): Percentage Breakdown of Number of Procedures by Procedure Type
INDIA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
  • Market Overview
  • Non-Surgical Aesthetic Procedures in India (2019): Percentage Breakdown of Number of Procedures by Procedure Type
SOUTH KOREA
  • Market Overview
  • Strong Demand for Cosmetic Procedures - Potential for BTX Market
  • Working Women as % of Total Female Population for 2005, 2010, 2015 & 2018
  • Foreign Patients Visiting Korea for Plastic Surgery & Dermatology Procedures as a % of Total Visits of Foreign Patients
  • Competition
  • Market Share of Leading Players in Botulinum Toxin Market In South Korea
REST OF ASIA-PACIFIC
LATIN AMERICA
  • Botulinum Toxin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
REST OF WORLDIV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Merz Pharma GmbH & Co. KGaA
  • Evolus, Inc.
  • Galderma SA
  • Daewoong Pharmaceutical Co., Ltd.
  • Revance Therapeutics, Inc.
  • Protox Co., Ltd.
  • Medy-Tox
  • Jetema Co., Ltd.
  • Hugel, Inc.